Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

41618

	registered interest
	date	05/03/2014
	answering body	Speaker's Committee for Independent Parliamentary Standards Authority
	answering dept id	90
	answering dept short name
	answering dept sort name
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the hon. Member for Broxbourne, representing the Speaker's Committee for the Independent Parliamentary Standards Authority, what procurement process was conducted by IPSA in advance of the decision to engage Matrix Chambers to prepare and advise on High Court action in May 2013 in respect of their case against the hon. Member for Peterborough; and if he will make a statement.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	190702
	answer	answer is ministerial correction date of answer 25/03/2014 answer text <p>The information requested falls within the responsibility of the Independent Parliamentary Standards Authority. I have asked IPSA to reply.</p><p>Letter from Andrew McDonald, March 2013:</p><blockquote><p>As Chief Executive of the Independent Parliamentary Standards Authority, I have been asked to reply to your Parliamentary Question asking about the engagement of Matrix Chambers.</p><p> </p>Counsel from Matrix Chambers were identified as one of IPSA's preferred legal Counsel as part of a tender exercise for legal services in 2010. Accordingly, Counsel from Matrix Chambers were instructed by IPSA's solicitors, Addleshaw Goddard LLP, in connection with the matter in March 2013.</blockquote><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Broxbourne answering member printed Mr Charles Walker question first answered 25/03/2014 12:00:00 answering member 1493 label Biography information for Sir Charles Walker
	tabling member	373 label Biography information for Sir David Davis

49345

	registered interest
	date	30/04/2014
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, how many directions under section 94 of the Telecommunications Act 1984 have been issued, amended or renewed in this Parliament.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	197254
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p> </p><p>Section 94 of the Telecommunications Act 1984 states that the Secretary of <br>State may issue directions in the interests of national security and, as with <br>the practice of previous Governments, we do not comment on security matters.</p><p> </p> answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire question first answered 08/05/2014 12:00:00 answering member 1530 label Biography information for James Brokenshire previous answer version 8403 answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire answering member 1530 label Biography information for James Brokenshire
	tabling member	373 label Biography information for Sir David Davis

50472

	registered interest
	date	09/05/2014
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, which body has been provided with copies of the section 94 directions issued by her in order to provide oversight since May 2010.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	198387
	answer	answer is ministerial correction date of answer 14/05/2014 answer text <p> </p><p>Section 94 of the Telecommunications Act 1984 states that the Secretary of <br>State may issue directions in the interests of national security. When <br>disclosure of these Directions would be contrary to interests of national <br>security or relations with the government of a country or territory outside the <br>United Kingdom or the commercial interests of any person, these are not laid <br>before the House. Consistent with the practice of successive Governments, we do <br>not comment on national security matters.</p><p> </p> answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire question first answered 14/05/2014 12:00:00 answering member 1530 label Biography information for James Brokenshire
	tabling member	373 label Biography information for Sir David Davis

1179948

	registered interest
	date	24/02/2020
	answering body	Department for Digital, Culture, Media and Sport
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	hansard heading	5G
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Digital, Culture, Media and Sport, with reference to the announcement by his Department on 20 February 2020 of a £65 million package for 5G trials, what the Government's policy is on security in the telecommunications supply chain in respect of those trials; and what decisions have been made in respect of the identity of the suppliers that will provide the infrastructure for those trials.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	19758
	answer	answer is ministerial correction date of answer 03/03/2020 answer text <p>The recent announcement of a new £65 million package of 5G trials forms part of the DCMS £200 million 5G Testbeds and Trials programme. That included £35 million for nine winning projects from our rural and industrial 5G competitions, and a new £30 million open competition - 5G Create - that will launch in due course.</p><p><strong> </strong></p><p>The Programme ensures that each of our projects has a security strategy in place that identifies and mitigates security risks and is proportionate for R&amp;D environments. Testbeds are encouraged to employ nationally recognised standards and best practice security approaches. This includes identifying and mitigating supply chain risks and taking steps to manage High Risk Vendors. None of the successful projects announced as part of Industrial 5G and Rural Connected Communities will use equipment from high risk vendors. We will publish guidance in due course for our 5G Create competition when it launches.</p><p> </p> answering member constituency Boston and Skegness answering member printed Matt Warman question first answered 03/03/2020 15:30:59 answering member 4361 label Biography information for Matt Warman
	tabling member	373 label Biography information for Sir David Davis

1582008

	registered interest
	date	30/01/2023
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	77th Brigade
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Defence, which Minister or official authorised the 77th Brigade to collect data related to public statements, social media and internet activity as part of its work.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	135142
	answer	answer is ministerial correction date of answer 14/02/2023 answer text <p>77th Brigade was created in 2015 and conducts information operations, including information activity and outreach, across a range of disciplines. This includes collecting, creating, and disseminating digital and wider media content in support of designated tasks. Like many Armed Forces units, 77th Brigade supported the national response to the COVID-19 pandemic and provided support to the Department for Culture, Media, and Sport, who were working to counter disinformation.</p> answering member constituency Wells answering member printed James Heappey question first answered 14/02/2023 12:02:12 answering member 4528 label Biography information for James Heappey
	tabling member	373 label Biography information for Sir David Davis

1182271

	registered interest
	date	03/03/2020
	answering body	Department for Transport
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	A63: Accidents
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Transport, how many road traffic collisions there have been on the A63 between the Ferensway Interchange (Central Hull) and North Cave Interchange in the last five; what the location was of those collisions; what serious injuries resulted from those collisions; and how many fatalities resulted from those collisions.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	24238
	answer	answer is ministerial correction date of answer 11/03/2020 answer text <p>The number of personal injury reported road accidents, fatal casualties and seriously injured casualties on the A63 between the Ferensway Interchange (Central Hull) and North Cave Interchange between 2014 and 2018 can be found in the table below.</p><p> </p><p>Reported road accidents and casualties on the A63 between the Ferensway Interchange (Central Hull) and North Cave Interchange, 2014-2018</p><table><tbody><tr><td><p> </p></td><td><p>2014</p></td><td><p>2015</p></td><td><p>2016</p></td><td><p>2017</p></td><td><p>2018</p></td></tr><tr><td><p>Personal injury accidents</p></td><td><p>46</p></td><td><p>55</p></td><td><p>44</p></td><td><p>44</p></td><td><p>44</p></td></tr><tr><td><p>Fatal casualties</p></td><td><p>0</p></td><td><p>0</p></td><td><p>1</p></td><td><p>0</p></td><td><p>2</p></td></tr><tr><td><p>Seriously injured casualties</p></td><td><p>5</p></td><td><p>8</p></td><td><p>7</p></td><td><p>14</p></td><td><p>6</p></td></tr></tbody></table><table><tbody><tr><td><p>Source: DfT, STATS19</p></td><td><p> </p></td></tr></tbody></table><p> </p><p> </p><p>Please note that the number of serious injuries provided is as reported by the police. Since 2016, changes in severity reporting systems for a large number of police forces (including for Humberside police force which covers the geographic area required) mean that serious injury figures, and to a lesser extent slight injuries, as reported by the police are not comparable with earlier years. Adjustments to account for the change have been produced for high level series in the Reported Road Casualties in Great Britain, annual report: 2018.</p><p> </p><p>Injury descriptions are available from the CRASH system only since January 2016 for Humberside police force. The most severe injury description as reported by the police for seriously injured casualties on the A63 between the Ferensway Interchange (Central Hull) and North Cave Interchange between 2016 and 2018 can be found in the attached Table A. Please note that this information is as reported by the police and is not the result of a medical assessment.</p><p> </p><p>The eastings and northings of each accident for the requested geographical area can be found in the attached Table B. The location of each accident can also be found in user-friendly online maps, for example on the THINK! website (<a href="https://www.think.gov.uk/thinkmap/" target="_blank">https://www.think.gov.uk/thinkmap/</a>).</p><p> </p> answering member constituency Rochester and Strood answering member printed Kelly Tolhurst attachment 1 file name Table A Injuries - A63 Central Hull & North Cave Interchange.docx title Injuries A63 Central Hull & North Cave Interchange 2 file name 281678_supporting - Table B - Road accidents A63 Central Hull & N Cave Interchange.xlsx title Road accidents A63 question first answered 11/03/2020 16:31:49 answering member 4487 label Biography information for Kelly Tolhurst
	tabling member	373 label Biography information for Sir David Davis

1668422

	registered interest
	date	08/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abiraterone
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of the level of availability of abiraterone on the NHS on the health of prostate cancer patients.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	672
	answer	answer is ministerial correction date of answer 17/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use of resources. The NHS is legally required to fund medicines recommended by NICE, usually within three months of final guidance.</p><p>NICE has published guidance recommending abiraterone for the treatment of hormone-relapsed metastatic prostate cancer before chemotherapy is indicated and for the castration-resistant variant of that cancer previously treated with a docetaxel-containing regimen. NHS England funds abiraterone for these indications of prostate cancer in line with NICE’s recommendations, making it routinely available for the treatment of eligible patients.</p><p>Abiraterone is not licensed for the treatment of non-metastatic prostate cancer and has therefore not been appraised by NICE for such use. NHS England is considering a clinical policy proposal for abiraterone as a treatment option for patients newly diagnosed with high risk, non-metastatic, hormone-sensitive prostate cancer, or in whom prostate cancer has relapsed after at least 12 months without treatment. This specific policy proposal is due to be discussed later in November 2023 and if supported by a clinical panel it will progress to stakeholder testing by January 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 673 674 question first answered 17/11/2023 12:37:56 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	373 label Biography information for Sir David Davis

1668423

	registered interest
	date	08/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abiraterone
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of bringing forward the planned review of abiraterone as a treatment for prostate cancer on the NHS.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	673
	answer	answer is ministerial correction date of answer 17/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use of resources. The NHS is legally required to fund medicines recommended by NICE, usually within three months of final guidance.</p><p>NICE has published guidance recommending abiraterone for the treatment of hormone-relapsed metastatic prostate cancer before chemotherapy is indicated and for the castration-resistant variant of that cancer previously treated with a docetaxel-containing regimen. NHS England funds abiraterone for these indications of prostate cancer in line with NICE’s recommendations, making it routinely available for the treatment of eligible patients.</p><p>Abiraterone is not licensed for the treatment of non-metastatic prostate cancer and has therefore not been appraised by NICE for such use. NHS England is considering a clinical policy proposal for abiraterone as a treatment option for patients newly diagnosed with high risk, non-metastatic, hormone-sensitive prostate cancer, or in whom prostate cancer has relapsed after at least 12 months without treatment. This specific policy proposal is due to be discussed later in November 2023 and if supported by a clinical panel it will progress to stakeholder testing by January 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 672 674 question first answered 17/11/2023 12:37:56 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	373 label Biography information for Sir David Davis

1668424

	registered interest
	date	08/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Abiraterone
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the cost effectiveness of the use of abiraterone as a treatment for prostate cancer by the NHS.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	674
	answer	answer is ministerial correction date of answer 17/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides evidence-based guidance for the National Health Service on whether new medicines represent a clinically- and cost-effective use of resources. The NHS is legally required to fund medicines recommended by NICE, usually within three months of final guidance.</p><p>NICE has published guidance recommending abiraterone for the treatment of hormone-relapsed metastatic prostate cancer before chemotherapy is indicated and for the castration-resistant variant of that cancer previously treated with a docetaxel-containing regimen. NHS England funds abiraterone for these indications of prostate cancer in line with NICE’s recommendations, making it routinely available for the treatment of eligible patients.</p><p>Abiraterone is not licensed for the treatment of non-metastatic prostate cancer and has therefore not been appraised by NICE for such use. NHS England is considering a clinical policy proposal for abiraterone as a treatment option for patients newly diagnosed with high risk, non-metastatic, hormone-sensitive prostate cancer, or in whom prostate cancer has relapsed after at least 12 months without treatment. This specific policy proposal is due to be discussed later in November 2023 and if supported by a clinical panel it will progress to stakeholder testing by January 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 672 673 question first answered 17/11/2023 12:37:56 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	373 label Biography information for Sir David Davis

1139242

	registered interest
	date	16/07/2019
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Agriculture: Subsidies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to support the farming and agriculture industry in (a) the UK, (b) Yorkshire and the Humber and (c) Haltemprice and Howden constituency.
	tabling member constituency	Haltemprice and Howden
	tabling member printed	Mr David Davis
	uin	277642
	answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>Farming has a bright future outside the EU’s Common Agricultural Policy. The Great Yorkshire Show demonstrated the strengths that British farming has to offer with a record-breaking number of entries for sheep and cattle, and great produce from Wensleydale cheese to North Yorkshire game.</p><p> </p><p>I know very well the importance of supporting these farmers in Yorkshire and Humber, home to my own constituency and farm, as well as my Rt Hon friend’s constituency, Haltemprice and Howden. As we prepare to leave the EU, the UK Government is taking a number of steps to support our farmers and industry in England and across the UK.</p><p> </p><p>For the UK as a whole, the Government has pledged to continue to commit the same cash total in funds for farm support until the end of this Parliament, expected in 2022; this includes all funding provided for farm support under both Pillar 1 and Pillar 2 of the current Common Agricultural Policy.</p><p /><p>The Government has also guaranteed that any projects where funding has been agreed before the end of 2020 will be funded for their full lifetime. This means, in the event the UK leaves the EU with no deal, the UK Government would fund any remaining payments to farmers, land managers and rural businesses due after October 2019. This would ensure continued funding for these projects until they finish. The guarantee also means that Defra and the devolved administrations can continue to sign new projects after the UK leaves the EU during 2019 and 2020.</p><p> </p><p>As agriculture is devolved, each administration will have the flexibility to develop agricultural policy suited to their own unique circumstances, once the UK has left the EU. It is for the Scottish, Welsh and future Northern Ireland Governments to decide upon future agricultural policies for their respective nations.</p><p> </p><p>For farmers in England, the Agriculture Bill marks a decisive shift in our support. We will create an ambitious new system based on paying “public money for public goods”. Public goods will include improving air and water quality, and habitats for wildlife. By paying for things the public value, we can also improve animal welfare and reduce the use of antibiotics in our food chain. Financial support for innovations like precision farming can help farmers become more productive, reduce the use of expensive chemicals and protect the environment.</p><p> </p><p>Critically, our Agriculture Bill also includes a seven year transition period of 2021–2027 for Direct Payments to help farmers in England to plan for the future. In the meantime direct payments for 2019 and 2020 will be made on the same basis as they are now, with simplifications where possible.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill question first answered 22/07/2019 12:01:27 answering member 1562 label Biography information for Sir Robert Goodwill
	tabling member	373 label Biography information for Sir David Davis